Stock Earnings

Question 1

What are Evoke Pharma Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Evoke Pharma Inc has a total asset of $17, Net loss of $-5

Question 2

What are the key financial ratios for EVOK?

Accepted Answer

Evoke Pharma Inc's Current ratio is 1.7, has a Net margin is -50, sales per share of $5.24.

Question 3

How is Evoke Pharma Inc's revenue broken down by segment or geography?

Accepted Answer

Evoke Pharma Inc largest revenue segment is Pharmaceutical Products, at a revenue of 10,249,415 in the most earnings release.For geography, United States is the primary market for Evoke Pharma Inc, at a revenue of 10,249,415.

Question 4

Is Evoke Pharma Inc profitable?

Accepted Answer

no, according to the latest financial statements, Evoke Pharma Inc has a net loss of $-5

Question 5

Does Evoke Pharma Inc have any liabilities?

Accepted Answer

yes, Evoke Pharma Inc has liability of 10

Question 6

How many outstanding shares for Evoke Pharma Inc?

Accepted Answer

Evoke Pharma Inc has a total outstanding shares of 1.48

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	12	10	5	2	1	0
Revenue Growth (YoY)	71%	100%	150%	100%	--	--
Cost of Revenue	0	0	0	0	0	0
Gross Profit	12	9	4	2	1	0
Selling, General & Admin	17	15	12	9	8	6
Research & Development	0	0	0	0	0	6
Operating Expenses	17	15	12	9	9	12
Other Non Operating Income (Expenses)	--	--	--	0	0	--
Pretax Income	-5	-5	-7	-8	-8	-13
Income Tax Expense	--	--	--	--	--	--
Net Income	-5	-5	-7	-8	-8	-13
Net Income Growth	-17%	-28.99%	-13%	0%	-38%	86%
Shares Outstanding (Diluted)	2.55	1.9	0.27	3.14	2.68	2.12
Shares Change (YoY)	87%	584%	-91%	17%	26%	14%
EPS (Diluted)	-2.1	-2.8	-27.97	-2.62	-3.18	-6.19
EPS Growth	-56%	-90%	968%	-18%	-49%	61%
Free Cash Flow	-3	-5	-4	-6	-12	-6
Free Cash Flow Per Share	-1.17	-2.62	-14.35	-1.91	-4.47	-2.83
Gross Margin	100%	90%	80%	100%	100%	0%
Operating Margin	-41.66%	-50%	-140%	-350%	-800%	0%
Profit Margin	-41.66%	-50%	-140%	-400%	-800%	0%
Free Cash Flow Margin	-25%	-50%	-80%	-300%	-1,200%	0%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-5	-5	-7	-7	-8	-13
EBIT Margin	-41.66%	-50%	-140%	-350%	-800%	0%
Effective Tax Rate	--	--	--	--	--	--

Evoke Pharma Inc (EVOK) Price

EVOK Stock Price Chart

EVOK Income

Follow-Up Questions